Maternal serum prenatal quadruple screening includes tests for alpha-fetoprotein (AFP), human chorionic gonadotrophin (hCG), unconjugated estriol (uE3), and dimeric inhibin A (DIA). Measurements of maternal serum AFP, uE3, and hCG, as well as maternal age, are widely used in the second trimester for the identification of pregnancies at high risk of Down syndrome [1, 2] . The maternal serum mid-trimester triple marker test is also a widely accepted protocol in Korea [3] [4] [5] . The triple test (AFP, uE3, hCG Background : Maternal serum prenatal quadruple screening includes testing for alpha-fetoprotein (AFP), human chorionic gonadotrophin (hCG), unconjugated estriol (uE3), and dimeric inhibin A (DIA). We evaluated quadruple screening using an automated platform and looked for any ethnic differences in the median values of each marker.
INTRODUCTION
mercially available for triple tests; however, DIA currently has only two platforms-either ELISA (Diagnostic Systems Laboratories, Webster, TX, USA) or the Beckman Coulter UniCel DxI 800 system or Access 2 (Beckman Coulter, Fullerton, CA, USA).
To date, DIA has been assayed using an ELISA method; however, this method is time consuming and requires considerable labor, thereby resulting in a long turnaround time.
However, Beckman Coulter has launched a DIA product that is used in conjunction with an automated chemiluminescence analyzer, and Lambert-Messerlian et al. [9] recently published median values for DIA using the Beckman Coulter Access immunoassay system in 570 women of European descent. We established the gestational age-specific second-trimester median values for each marker of the quadruple test in Korean second-trimester pregnant women using the Beckman Coulter UniCel DxI 800 immunoassay system in order to make it applicable for use in the Korean population. In addition, we compared the results of the test for each marker using the UniCel DxI 800 system with those obtained using either the Immulite 2000 assay (Siemens Healthcare Diagnostics, Deerfield, IL, USA) or ELISA.
MATERIALS AND METHODS
We recruited 788 pregnant Korean women at 15 to 20 weeks gestation who visited the clinics of Yonsei University Health System, or the clinics that refer the quadruple test to Seoul Clinical Laboratories for prenatal checkups.
We stored serum samples from each patient in a deep freezer at -70℃ after completion of the requested quadruple marker tests using the Immulite 2000 assay or ELISA, and subsequently used these samples for the measurement of beta-hCG, AFP, uE3, and DIA using the UniCel DxI 800 system. Clinical Laboratories, an independent medical laboratory.
We used the completed week for gestational age estimation.
Exclusion criteria for the subjects were as follows: and Bland-Altman plots were generated using Analyse-It software version 1.71 (Leeds, UK).
RESULTS
Total coefficients of variation (CV) were estimated according to CLSI Guideline EP5-A2 [10] and the results ranged from 2.1% to 5.8% for low, from 2.8% to 5.8% for middle, and from 3.8% to 5.4% for high variation (Table 1) .
Method comparisons were performed using Passing-Bablok regression and Bland-Altman plots. Passing-Bablok regression produced variable slopes ranging from 0.28 to The median values for each of the four markers at [15] [16] [17] [18] [19] [20] weeks of gestations are presented in Table 2 .
DISCUSSION
All quadruple test assays conducted using the UniCel DxI 800 immunoassay system yielded results comparable with those obtained using the Immulite 2000 assay or ELISA, but with significant bias, thus necessitating the calculation of median values for prenatal risk estimation. The number of 19th week subjects was slightly less than the recommended number of 100 and there were only 17 subjects in the 20th week. However, the number of subjects in the 15th to the 18th gestational weeks was sufficient for regression analysis of the results for each marker. The median values of DIA in these Korean samples appeared to be higher than those in Western samples [9] (Table 3) .
Rawlins et al. [11] reported that DIA Access and ELISA DIA precision (within-run CV, 3.9-5.3%; total CV, 3.9-5.4%) in our study was similar to that of Rawlins et al. [11] (within-run CV, 3.2-3.6%; total CV, 4.1-4.2%) for similar levels ( have not been reported for Asians [16] . Our study showed similar median values for uE3. Benn et al. [17] postulated that the differences observed in the various studies may be attributable to the inconsistent use of maternal weight correction, heterogeneity in the gestational ages of the screened populations, maternal age differences, and regional differences in the subpopulations of women included in each group.
In addition, Benn et al. [18] and Serdar et al. [19] reported that analytical variations have a great impact on second trimester risk estimation procedures and some articles have reported borderline cases as being problematic [18, 20] . A survey report of external quality control samples for 9 clinical laboratories in Korea showed variable results for the borderline cases that necessitated standardization [21] .
An automated platform for quadruple screening has several advantages over manual ELISA, namely, better preci- 
